跳到正文

Crystal Adam 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Crystal Adam(CIK 1825445)在 1 家公司共报告 28 笔 SEC Form 4 内部人交易(最近一笔 2026-10-05)。

日期公司身份类型股数市值
2026-10-05Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-10-05Tango Therapeutics, Inc. (TNGX)President, R&D卖出26,400$645,604
2026-10-05Tango Therapeutics, Inc. (TNGX)President, R&D卖出600$15,192
2026-09-03Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-09-03Tango Therapeutics, Inc. (TNGX)President, R&D卖出27,000$603,909
2026-08-05Tango Therapeutics, Inc. (TNGX)President, R&D卖出5,267$141,100
2026-08-05Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-08-05Tango Therapeutics, Inc. (TNGX)President, R&D卖出21,733$594,417
2026-07-02Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-07-02Tango Therapeutics, Inc. (TNGX)President, R&D卖出19,629$575,962
2026-07-02Tango Therapeutics, Inc. (TNGX)President, R&D卖出7,371$222,946
2026-06-03Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-06-03Tango Therapeutics, Inc. (TNGX)President, R&D卖出20,860$481,032
2026-06-03Tango Therapeutics, Inc. (TNGX)President, R&D卖出6,140$136,615
2026-05-05Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-05-05Tango Therapeutics, Inc. (TNGX)President, R&D卖出25,900$548,821
2026-05-05Tango Therapeutics, Inc. (TNGX)President, R&D卖出1,100$24,200
2026-04-16Tango Therapeutics, Inc. (TNGX)President, R&D买入38,460$199,992
2026-04-16Tango Therapeutics, Inc. (TNGX)President, R&D卖出38,460$961,500
2026-04-02Tango Therapeutics, Inc. (TNGX)President, R&D买入27,000$140,400
2026-04-02Tango Therapeutics, Inc. (TNGX)President, R&D卖出27,000$572,400
2026-03-27Tango Therapeutics, Inc. (TNGX)President, R&D买入12,000$62,400
2026-03-27Tango Therapeutics, Inc. (TNGX)President, R&D卖出12,000$241,320
2026-03-09Tango Therapeutics, Inc. (TNGX)President, R&D卖出20,251$303,765
2026-02-27Tango Therapeutics, Inc. (TNGX)President, R&D卖出54,345$693,986

来源:SEC Form 4 申报文件 · 截至 2026-10-05